Tandem Diabetes Care reports a 2Q growth of $222 million in 2024 By Investing.com
Tandem Diabetes Care, Inc. (NASDAQ:), a leading medical device company, has reported a significant second-quarter sales growth of $222 million...
Tandem Diabetes Care, Inc. (NASDAQ:), a leading medical device company, has reported a significant second-quarter sales growth of $222 million...
3M receives $34.2 million award to improve treatment of traumatic wounds from point-of-injury to hospitalST. PAUL, Minn., Jan. 10, 2024 /PRNewswire/...